*To be consumed as directed by physician.
Therapies:
Supportive
Composition:
Eltrombopag 50 mg
Rompag 50 mg Tablets contains Eltrombopag 50 mg, a thrombopoietin receptor agonist used to increase platelet production in patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP), thrombocytopenia associated with chronic hepatitis C virus (HCV) infection, and severe aplastic anemia. It works by stimulating the bone marrow to produce more platelets, thereby helping reduce the risk of bleeding. Rompag 50 mg Tablets should be used only under the supervision of a qualified healthcare professional, with regular monitoring of platelet counts and liver function.
*To be consumed as directed by physician.